Email this article 
Synthesis and properties of 1,3-disubstituted ureas bearing adamantyl and pyridin(quinolin)yl moieties
- Authors: Baykova S.O1, Baykov S.V1, Petrov A.A1, Bumistrov V.V2, Boyarskiy V.P1
-
Affiliations:
- St Petersburg State University, Institute of Chemistry
- Volgograd State Technical University
- Issue: Vol 59, No 7 (2023)
- Pages: 910-919
- Section: Articles
- URL: https://journal-vniispk.ru/0514-7492/article/view/141659
- DOI: https://doi.org/10.31857/S0514749223070054
- EDN: https://elibrary.ru/HSRVKC
- ID: 141659
Cite item
Open Access
Access granted
Subscription Access
Abstract
A series of 1,3-disubstituted ureas containing pyridine (quinoline) and lipophilic adamantane moieties was synthesized by the reaction of 1,1-dimethyl-3-(hetaryl)ureas with amine hydrochlorides (13 compounds, 53-94% yields). The synthesized compounds differ from each other in the substitution position of the adamantane fragment, the structure of the alkyl linker between the adamantane fragment and the amide group, and the type of heterocyclic substituent. They are potentially targeted inhibitors of human soluble epoxide hydrolase (sEH).
About the authors
S. O Baykova
St Petersburg State University, Institute of Chemistry
S. V Baykov
St Petersburg State University, Institute of Chemistry
A. A Petrov
St Petersburg State University, Institute of Chemistry
Email: aap1947@yandex.ru
V. V Bumistrov
Volgograd State Technical University
V. P Boyarskiy
St Petersburg State University, Institute of Chemistry
Email: v.boiarskii@spbu.ru
References
- Korkmaz H. SDÜ Tıp Fakültesi Derg. 2021, 28, 171-175. doi: 10.17343/sdutfd.904540
- Schopman J.E., Simon A.C.R., Hoefnagel S.J.M, Hoekstra J.B.L., Scholten R.J.P.M., Holleman F. Diabetes Metab. Res. Rev. 2014, 30, 11-22. doi: 10.1002/dmrr.2470
- Brown J.R., North E.J., Hurdle J.G., Morisseau C., Scarborough J.S., Sun D., Korduláková J., Scherman M.S., Jones V., Grzegorzewicz A., Crew R.M., Jackson M., McNeil M.R., Lee R.E. Bioorg. Med. Chem. 2011, 19, 5585-5595. doi: 10.1016/j.bmc.2011.07.034
- Dorrance A.M., Rupp N., Pollock D.M., Newman J.W., Hammock B.D., Imig J.D. J. Cardiovasc. Pharmacol. 2005, 46, 842-848. doi: 10.1097/01.fjc.0000189600.74157.6d
- Hwang S.H., Wecksler A.T., Zhang G., Morisseau C., Nguyen L.V., Fu S.H., Hammock B.D. Bioorg. Med. Chem. Lett. 2013, 23, 3732-3737. doi: 10.1016/j.bmcl.2013.05.011
- Hiesinger K., Wagner K.M., Hammock B.D., Proschak E., Hwang S.H. Prostaglandins Other Lipid Mediat. 2019, 140, 31-39. doi: 10.1016/j.prostaglandins.2018.12.003
- Imig J.D., Zhao X., Zaharis C.Z., Olearczyk J.J., Pollock D.M., Newman J.W., Kim I.-H., Watanabe T., Hammock B.D. Hypertension. 2005, 46, 975-981. doi: 10.1161/01.HYP.0000176237.74820.75
- Das Mahapatra A., Choubey R., Datta B. Molecules. 2020, 25, 5488. doi: 10.3390/molecules25235488
- Wagner K.M., McReynolds C.B., Schmidt W.K., Hammock B.D. Pharmacol. Ther. 2017, 180, 62-76. doi: 10.1016/j.pharmthera.2017.06.006
- Burmistrov V., Morisseau C., Harris T.R., Butov G., Hammock B.D. Bioorg. Chem. 2018, 76, 510-527. doi: 10.1016/j.bioorg.2017.12.024
- Morisseau C., Hammock B.D. Annu. Rev. Pharmacol. Toxicol. 2013, 53, 37-58. doi: 10.1146/annurev-pharmtox-011112-140244
- Burmistrov V., Morisseau C., Karlov D., Pitushkin D., Vernigora A., Rasskazova E., Butov G. M., Hammock B.D. Bioorg. Med. Chem. Lett. 2020, 30, 127430. doi: 10.1016/j.bmcl.2020.127430
- Wanka L., Iqbal K., Schreiner P.R. Chem. Rev. 2013, 113, 3516-36142. doi: 10.1021/cr100264t
- Rassadin V.A., Zimin D.P., Raskil'dina G.Z., Ivanov A.Y, Boyarskiy V.P, Zlotskii S.S., Kukushkin V.Y. Green Chem. 2016, 18, 6630-6636. doi: 10.1039/C6GC02556K
- Geyl K., Baykov S., Tarasenko M., Zelenkov L.E, Matveevskaya V., Boyarskiy V.P. Tetrahedron Lett. 2019, 60, 151108. doi: 10.1016/j.tetlet.2019.151108
- Kasatkina S.O., Geyl K.K., Baykov S.V., Boyarskaya I.A., Boyarskiy V.P. Org. Biomol. Chem. 2021, 19, 6059-6065. doi: 10.1039/D1OB00783A
- Baykov S., Mikherdov A., Novikov A., Geyl K., Tarasenko M., Gureev M., Boyarskiy V. Molecules. 2021, 26, 5672. doi: 10.3390/molecules26185672
- Kasatkina S.O., Geyl K.K., Baykov S.V., Novikov M.S., Boyarskiy V.P. Adv. Synth. Catal. 2022, 364, 1295-1304. doi: 10.1002/adsc.202101490
- Baykova S.O., Geyl K.K., Baykov S.V., Boyarskiy V.P. Int. J. Mol. Sci. 2023, 24, 7633. doi: 10.3390/ijms24087633
- Zhu X., Xu M., Sun J., Guo D., Zhang Y., Zhou S., Wang S. Eur. J. Org. Chem. 2021, 5213-5218. doi: 10.1002/ejoc.202100932
- North E.J., Scherman M.S., Bruhn D.F., Scarborough J.S., Maddox M.M., Jones V., Grzegorzewicz A., Yang L., Hess T., Morisseau C., Jackson M., McNeil M.R., Lee R.E. Bioorg. Med. Chem. 2013, 21, 2587-2599. doi: 10.1016/j.bmc.2013.02.028
- Abraham R.J., Griffiths L, Perez M. Magn. Reson. Chem. 2014, 52, 395-408. doi: 10.1002/mrc.4079
- Molinspiration Chemoinformatic Software, URL: https://www.molinspiration.com
- Sheldrick G.M. Acta Crystallogr., Sect. A. 2015, 71, 3-8. doi: 10.1107/S2053273314026370
- Sheldrick G.M. Acta Crystallogr., Sect. C. 2015, 71, 3-8. doi: 10.1107/S2053229614024218
- Dolomanov O.V., Bourhis L.J., Gildea R.J., Howard J.A.K., Puschmann H. J. Appl. Crystallogr. 2009, 42, 339-341. doi: 10.1107/S0021889808042726
Supplementary files
